Study type: Human research · Status: Verified against declared source

The Role of Cathelicidin LL-37 in Cancer Development.

Archivum immunologiae et therapiae experimentalis · 2016

Study scale: Not reported

Abstract only: Open source record

Product or molecular entity relationships

LL-37: Exact entity relationship. Legacy citation custody associates this source with the catalog record; no product-relevance conclusion is implied.

Plain-language verified summary

Question

Not reported in the reviewed source.

Methods

Not reported in the reviewed source.

Scale or participants

Not reported in the reviewed source.

Key findings

LL-37 is a C-terminal peptide proteolytically released from 18 kDa human cathelicidin protein (hCAP18).

Limitations and uncertainty

Not reported in the reviewed source.

Verified against declared source. Verification is limited to the declared source and review scope. It does not mean independent replication or establish efficacy, safety, or suitability.